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Abstract
The infectivity of Human Immunodeficiency Virus is critically dependent on
successful incorporation of the trimeric viral envelope glycoprotein, Envelope
(Env), into Gag lattice assembly sites on the host-cell plasma membrane during
virus biogenesis. The mechanistic nature of interaction between Gag, the
structural protein, and Env, the viral spike, are dependent on the Gag matrix
(MA) and Env cytoplasmic tail (CT) domains. Env laterally diffuses on the host
cell plasma membrane until encountering a budding Gag lattice, where it is
retained until particle scission and release. The mechanism of Env entry and
retention in the lattice remains elusive and enigmatic. Here I aim to address the
biophysical mechanisms that regulate the coalescence of these proteins through
single-molecule and biochemical approaches. I provide a framework for
quantifying the retention of Env at budding HIV-1 assembly sites using
simultaneous single-particle tracking with respect to superresolution
reconstructions of the viral bud on living cells in real time. Using this approach
and a novel competitive inhibition assay, I also provide evidence that a
monomeric Env CT is sufficient for virus particle incorporation and retention.
Validation of monomeric retention and limited lattice accommodation provides
evidence for a druggable interface that may be important for future antiretrovirals
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targeting the assembly of HIV. Lastly, I aim to provide a foundation for
understanding the mechanistic interaction between Env-CT monomers and the
Gag lattice by evaluating the retention and competitive properties of individual
Env-CT domains in cellulo—a process difficult to achieve through mutations of
the native Env trimer.
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Chapter One: Introduction
Decades of research have demonstrated that the viral envelope glycoprotein,
Env, must be presented on the surface of virus particles for HIV-1 to be
infectious. This viral spike drives the upstream events necessary for entry into
naïve t-cells: binding to the host cell receptors, CD4 and CXCR4/CCR5, and
initiation of virus-cell membrane fusion (Durham and Chen, 2015; Ho et al., 1988;
Lu et al., 2019; Munro et al., 2014). This transmembrane spanning glycoprotein
incorporates into the virus particle after traveling through a well characterized
biosynthetic pathway, where it undergoes multiple post-translational
modifications before arriving on the host-cell plasma membrane. Here, our
laboratory has shown that Env then diffuses laterally until encountering the
budding HIV structural scaffold, Gag—remaining trapped until the virus is finally
excised and free to infect other cells (Buttler et al., 2018; Pezeshkian et al.,
2019). In this chapter, I aim to briefly generalize the HIV-1 assembly process for
clarity.
HIV-1 Host-cell Entry and Infection
An HIV virion begins its replication cycle upon Env-initiated virus-cell
membrane fusion with a naïve host cell. The gp120 ectodomain of Env initially
binds the T-cell receptor CD4 and co-receptor CXCR4 or CCR5, depending on
tropism of the virus (Durham and Chen, 2015; Ma et al., 2018; Yang et al., 2005).
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The viral spike then undergoes a conformational change to bring the virus and
cell membrane into proximity, where they can fuse. Upon membrane fusion, the
virus expels the viral capsid core containing the necessary machinery to infect
the host cell, and propagate, into the host-cell cytoplasm (Bedinger et al., 1988;
Jouvenet et al., 2008; Lu et al., 2019). While this capsid core traverses the
cytoplasm towards the nucleus through a dynein mediated mechanism, reverse
transcription of the viral RNA occurs, [22] forming viral DNA and the reverse
transcription complex (RTC) (Carnes et al., 2018; Iordanskiy and Bukrinsky,
2007) . Although highly contested, the viral capsid has been shown to transport
through the nuclear pore complex, transporting the RTC and pre-integration
complex into the nucleus (Zila et al., 2021). Once in the nucleus, the viral
integrase (IN) catalyzes the integration of the viral DNA into the host cell
genome. From here, transcription occurs to produce mRNA of the accessory
proteins Tat, Rev and Nef, which help facilitate the downstream nuclear export
and translation of viral RNA (Malim and Emerman, 2008). Two of these latestage proteins that arise from this viral genetic content are the structural
components necessary for assembling infectious progeny virus—Gag and Env.
HIV-1 Gag biosynthesis, assembly, and maturation
In the late stages of the HIV replication cycle, Gag is produced as a soluble
multidomain protein in the cytosol. Gag is comprised of Matrix (MA), Capsid
(CA), Nucleocapsid, and p6 domains (Alfadhli et al., 2009a). The polyprotein,
Gag-Pol, is also produced, albeit in lower abundance than Gag alone. Gag-Pol is
produced through a frameshifting event that results in a small portion of the total
2

Gag structural protein produced (Wang et al., 2019). The expression of Pol is
necessary for post-entry infection of new host-cells, as it contains the viral
reverse transcriptase, protease and IN. However, Pol is dispensable for the
assembly of new virions (Alfadhli et al., 2009a; Eastep et al., 2021). Therefore, I
will refer to Gag and Gag-Pol as “Gag”.
Once translated, individual Gag proteins target the plasma membrane (PM)
after post-translational myristoylation. At the PM, Gag trimerizes through MA-MA
interactions. These trimers then hexamerize through CA-CA interactions, forming
a Gag lattice that spontaneously buckles the membrane and buds out from the
cell (Alfadhli et al., 2009a; Ono et al., 2004; Saad et al., 2006). These viral buds
statically reside on the PM until full incorporation of the viral genome and viral
spike, Env (Freed and Martin, 1995a). During the assembly process, the p6
domain of Gag recruits the endosomal sorting complex required for transport
(ESCRT) through binding of TSG-101, or ESCRT-I (Hoffman et al., 2019;
Ivanchenko et al., 2009; Van Engelenburg et al., 2014). The viral bud is then
excised by the ESCRT machinery and liberated from the host-cell body. This
virion undergoes a maturation process where the pH-sensitive PR cleaves Gag
between the MA and CA domains. Upon cleavage, MA undergoes a
conformational change and resides on the viral membrane, while CA forms a
conical core that houses the ribonucleoprotein complex. At this point the virion
can infect a new host-cell (Qu et al., 2021; Tan et al., 2021).
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HIV-1 Env biosynthesis and incorporation
The viral glycoprotein, Env, is synthesized, secreted, and cotranslationally folded in the endoplasmic reticulum (ER) membrane as the gp160
polyprotein precursor using a secretion signal peptide on its N-terminus
(Checkley et al., 2011). The gp160 precursor is comprised of luminal,
transmembrane, and cytosolic domains that trimerize and undergo N-linked and
O-linked glycosylation in the ER (Freed and Martin, 1995b). Upon trimerization,
gp160 is trafficked to the Golgi complex where it is proteolytically cleaved by the
host-enzyme furin into gp120 (luminal) and gp41 (transmembrane spanning and
cytosolic) (Checkley et al., 2011) subunits. These domains stay associated
through noncovalent interaction and traffic to the Golgi network, where gp120 is
further glycosylated (Cao et al., 2017). The resulting heterotrimeric glycoprotein
is trafficked to the plasma membrane where it can stochastically diffuse until it is
either rapidly endocytosed through a clathrin-mediated pathway or trapped in a
budding Gag lattice (Buttler et al., 2018; Byland et al., 2007; Groves et al., 2020;
Jouvenet et al., 2008; Pezeshkian et al., 2019; Wyss et al., 2001). This virion
incorporated Env becomes highly confined in the lattice, andresides in the Gag
bud until virion excision (Chojnacki et al., 2017; Chojnacki and Eggeling, 2021;
Groves et al., 2020; Pezeshkian et al., 2019).
The retention of Env in the viral bud was previously shown to be mediated
by the inner leaflet of the PM, which is proximal to the membrane-associated
Gag MA and Env CT domains; although the biochemical and biophysical
mechanisms of Env incorporation and retention are not well understood (Alfadhli
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et al., 2019, 2009b; Buttler et al., 2018; Freed and Martin, 1996; Groves et al.,
2020; Murakami and Freed, 2000; Pezeshkian et al., 2019). Previous work has
shown that membrane curvature, induced by the Gag lattice, and endocytic
motifs in the Env-CT are dispensable for Env incorporation—pointing to a
potential direct MA-CT interaction (Pezeshkian et al., 2019). In fact, in vitro and in
virio biochemical assays have elucidated that some oligomeric MA-CT affinity
exists in the absence and depletion of lipid membrane and host-cell factors,
although it remains unclear whether these interactions are sufficient for Env
retention during native assembly—or if this interaction is simply one component
to a larger incorporation mechanism (Alfadhli et al., 2019, 2009b; Wyma et al.,
2000). While the field has collectively identified mutations in both Env-CT and
Gag-MA that abrogate Env incorporation and virus infectivity, it is unclear
whether these mutations incur structural deformations of the oligomeric
quaternary structures of Env and Gag (Alfadhli et al., 2019; Eastep et al., 2021;
Freed and Martin, 1996; Kiernan et al., 1999). A recent NMR structure of gp41
showed that the cytoplasmic tails of Env oligomerize to form a spiral baseplate
structure. The function of this structure has yet to be determined; and it is unclear
whether mutations in the Env-CT disrupt this baseplate. Unraveling of the EnvCT baseplate could, in theory, indirectly disrupt Env-Gag interactions through
defects in biosynthesis, trafficking, endocytosis or diffusion on the membrane.
In the following chapters, I aim to address some of these issues by 1)
providing a nanoscale imaging methodology for studying the biophysical behavior
of Env on the PM of living cells during virus assembly; 2) examining the
5

stoichiometry of the Env-CT necessary for bona-fide incorporation during
assembly in native and mutant Gag-MA lattices; and 3) addressing preliminary
work towards elucidating a minimal motif in the Env-CT that may be used as a
future therapeutic agent to disrupt Env incorporation into HIV-1 virions.

6

Chapter Two: A Quantitative Live-Cell Superresolution Imaging Framework
for Measuring the Mobility of Single Molecules at Sites of Virus Assembly
Introduction
Since its inception, superresolution microscopy has been broadly adapted to
many fields of biological study (Betzig et al., 2006; Hell, 2007; Hess et al., 2006;
Rust et al., 2006; Schermelleh et al., 2008). Such methods offer molecular
specificity and resolution improvements up to 10-fold over conventional
diffraction-limited microscopy, enabling the reconstruction of biological
assemblies approaching tens of nanometers (Buttler et al., 2018). With these
tools in hand, researchers have been able to assess cellular spatial organization
of molecular assemblies created by pathogens, enabling the nanoscale
visualization of host–pathogen interfaces (Floderer et al., 2018; Gray et al., 2016;
Han et al., 2014; Hess et al., 2007; Horsington et al., 2013; Laine et al., 2015; Liu
et al., 2018; Zhang et al., 2017). In particular, superresolution imaging has
provided powerful insight into the mechanisms of human immunodeficiency virus1 (HIV-1) particle biogenesis and maturation (Boutant et al., 2020; Buttler et al.,
2018; Chojnacki et al., 2012; Fogarty et al., 2014; Gunzenhäuser et al., 2012;
Hendrix et al., 2015; Lehmann et al., 2011; Muranyi et al., 2013; Pereira et al.,
2012; Roy et al., 2013; Van Engelenburg et al., 2014).
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While these studies have been powerful for uncovering new aspects of
protein organization during HIV-1 biogenesis, this methodology has been largely
relegated to time-independent measurements and lacks spatiotemporal
information regarding viral protein coalescence. These shortcomings have been
addressed using fluorescence recovery after photobleaching (FRAP) to measure
bulk diffusion rates for viral molecules, however, this technique cannot provide
resolution below the diffraction-limit (Sakin et al., 2017). Stimulated emission
depletion microscopy in conjunction with scanning fluorescence correlation
spectroscopy (STED-FCS) presents a route to measure diffusion rates of viral
molecules below the resolution limit of the light microscope (Chojnacki et al.,
2017). In addition, single particle tracking (SPT) is an orthogonal and readily
accessible method that can provide spatiotemporal information of single viral
molecule dynamics on the scale of one to tens of nanometers (Pezeshkian et al.,
2019). Combinations of both STED and SPT have also been demonstrated
(Inavalli et al., 2019).
Upon infection, HIV-1 Gag oligomerizes on the inner leaflet of the plasma
membrane in T-cells by a cooperative interaction between its N-terminal
membrane-binding domain and internal Capsid (CA) oligomerization domain
(Alfadhli et al., 2009b; Gamble et al., 1997; Li et al., 2000; Ono et al., 2004; Saad
et al., 2006). After reaching a critical mass of oligomers, the forming lattice will
buckle the plasma membrane to create a virus bud (Ivanchenko et al., 2009;
Jouvenet et al., 2008). In order to form an infectious particle, the HIV-1 envelope
glycoprotein (Env) must traffic from the biosynthetic pathway to reach the plasma
8

membrane. Upon reaching the plasma membrane, Env freely diffuses and either
becomes trapped in a newly formed Gag lattice or is endocytosed (Byland et al.,
2007; Checkley et al., 2011). Previously, we described the spatiotemporal
dynamics of HIV-1 Env on a sub-viral scale (tens of nanometers) during HIV-1
biogenesis on living cells (Pezeshkian et al., 2019). Our SPT method allowed for
simultaneous measurement of heterogeneous diffusion modalities and trapping
of Env at sites of Gag lattice formation, which was dependent upon residues in
both Gag and Env. Our previous approach relied on conservative estimates of
Env proximity to Gag lattices due to diffraction-limited resolution of virus
assembly sites, creating uncertainty in the location of the perimeter of these
assembly sites. For strong phenotypic differences this uncertainty becomes
negligible, however, this error becomes significant as genetic phenotypes
become more nuanced. Herein, we expand on our previous methodology by
providing a framework for measuring live-cell nanoscale dynamics using
superresolution photo-activated localization microscopy (PALM) of the Gag
lattice paired with single particle tracking of HIV-1 Env. Although we have
focused this methodology on HIV-1 assembly, this method is broadly applicable
to other virus species and microbial receptor interactions.
Materials and Methods
Reagents
The HEK293T (CRL-3216) cell lines were obtained from ATCC (Manassas,
VA, USA). The CEM-A cell line was obtained through the NIH AIDS Reagent
Program, Division of AIDS, NIAID, NIH: CEM-A from Dr. Mark Wainberg and Dr.
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James McMahon, CEM-CL10 (Tremblay et al., 1989). Cell lines were grown at
37 ◦C with 5% CO2. Complete growth medium for HEK293T cells was prepared
by combining 10% fetal bovine serum (Corning; Corning, NY, USA), 2 mM Lglutamine (Corning), and Penicillin-Streptomycin (Corning) into Dulbecco’s
Modified Eagle’s Medium (DMEM) (Corning) or for the CEM-A cell line with
identical ingredients into Roswell Park Memorial Institute (RPMI) medium
(Corning). Additionally, the CEM-A cell line growth medium was supplemented
with 1% hypoxanthine, thymidine (HT) solution (Corning)
Generation of CA-Skylan-S Expressing Viruses
The pSV-NL4-3 reference HIV-1 genome was used for all experiments with
constructs possessing deletions in the gag-p6 late-domain, pol, vif, vpr, and nef
genes (Buttler et al., 2018). To create viral vectors coexpressing the CA-SkylanS nanobody, the coding region for the anti-CA nanobody was genetically fused to
the Skylan-S gene with a coding amino acid linker of:
‘RSFEFCSRRYRGPGIHRPVAT’. The CA-Skylan-S probe cassette was amplified
with 50 and 30 Gibson homology arms against the coding regions of the 30 end
of env and 50 end of the nef coding regions, respectively. Replication
incompetent viruses harboring the CA-Skylan-S nanobody cassette in the nef
splice site were produced by transfecting HEK293T cells with pSV-NL4-3
(described aboe) vector, pSPAX2 (Addgene, plasmid #12260), and pVSV-G
(Addgene, plasmid #8454). Supernatants from cells expressing for 48 h were
stored at −80 ◦C prior to infection.
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Monovalent BG-18-QD625 Production
The BG18 anti-Env V3 glycan-binding light and heavy chain antibody
sequences were obtained from the Protein Data Bank (6CH9) (Barnes et al.,
2018). The fragment of antigen binding sequences were synthesized (IDT;
Coralville, IA, USA) and cloned into the pCOMB3H-b12 vector using SacI and
NotI sites, replacing the b12 fab coding sequence (Barbas et al., 1994). The pIII
region of pCOMB3H was suppressed by introduction of a stop codon at the end
of the BG18 heavy chain CH1 domain. The light chain gene fragment from BG18
was engineered to contain a 30 amber stop codon (TAG) followed by a 6-fold
repeat of histidine codons, finalized with an ochre stop codon (TAA). Periplasmic
expression of BG18 fab containing a C-terminal p-azido-L-phenylalanine (pAZF)
unnatural amino acid (Bachem; Torrance, CA, USA) was performed in
Escherichia Coli XL1 Blue competent cells (Stratagene; San Diego, CA, USA) by
co-transformation with pCOMB3H-BG18-LC-Amber-His6-Ochre and pEVOLpAzF. Briefly, this strain was grown in 1–2 L of Super Broth medium containing
selective antibiotics. At mid-log phase, 1 mM unnatural amino acid pAZF was
added to the culture and expression of unnatural tRNAs and synthetase was
induced with 2% (w/v) L-arabinose (Gold Biotechnology; St. Louis, MO, USA).
Cellular lysates were produced by sonication in PBS pH 7.4 supplemented with
0.2 mM PMSF (Gold Biotechnology). Soluble proteins were clarified via
centrifugation at 30,000× g for 30 min and filtration by 0.22 µm cellulose acetate
syringe filter. BG18 fab that successfully suppressed the amber stop codon with
pAZF was purified using Nickel affinity chromatography (Gold Biotechnology)
11

followed by purification using CaptureSelect CH1-XL affinity chromatography
resin (Thermo Scientific; Waltham, MA, USA). Elution fractions were pooled and
dialyzed overnight in PBS, pH 7.4. Expression was assessed (Figure 2F) by
SDS-PAGE analysis on 4–20% gradient gel (Bio-Rad; Hercules, CA, USA). The
final yields from 1–2 L of culture were typically in the range of 1–3 mg of BG18pAzF. Copper-free click chemistry was performed between DIBO-QD625 (SiteClick kit, Thermo Scientific) and BG18-pAzF using a 1:1.5-fold stoichiometry,
respectively. The reaction was allowed to proceed for 12–18 h at room
temperature in the dark. Uncoupled DIBO-QD625 was removed from the reaction
by another round of CaptureSelect CH1-XL affinity chromatography. Elution
fractions were pooled and unreacted BG18-pAzF, lacking a DIBO-QD625
conjugate, was removed by filtration through a 100 KDa molecular weight cutoff
filter (Site-Click kit) followed by repeated buffer exchanges with PBS, pH 7.4.
Sample Preparation and Imaging Conditions
CEM-A T-cells in complete RPMI medium were dispensed onto 25 mm No.
1.0 glass coverslips (Warner Instruments; Hamden, CT, USA) at high density and
allowed to adhere for 18–24 h at 37 ◦C and 5% CO2. Cells were infected with
replication-incompetent (single-round infection) virus and incubated for 38–46 h
prior to imaging. Coverslips were transferred to specimen holders and mounted
on a custom-built ring-TIRF microscope with an environmental chamber
maintaining 37 ◦C and 5% CO2 previously described (Pezeshkian et al., 2019).
Briefly, BG18-QD625 and CA-Skylan-S probes were both excited with 473 nm
laser light (50 mW at rear aperture) and fluorescence was detected by separating
12

the respective wavelengths with a dichroic beamsplitter and W-View Gemini
image splitter (Hamamatsu, Hamamatsu City, Japan). Images of each channel
were then focused onto two halves of a liquid cooled ORCA Fusion scientificCMOS camera (C14440-20UP). Images were streamed at 100 Hz.
Image Processing and Analysis
All imaging, single molecule localization, and channel registration was done
per Pezeshkian et. al., 2019 (Pezeshkian et al., 2019). Briefly, raw images were
corrected for non-uniform pixel offset by use of a calibration map and were
subsequently split based on wavelength. For CA-Skylan-S, frames with 10 ms
exposure were integrated to 50 ms before single molecule localization and fitting
using custom software (IDL, Harris Geospatial; Broomfield, CO, USA). A high
density map of bead localizations using TetraSpeck fiducials (Thermo Fisher
Scientific) was used to create a polywarp transform using the cp2tform function in
Matlab (Mathworks, Natick, MA, USA) to correct for lateral chromatic aberration
between the channels. Single molecule localizations were then handed to an
automated package written in MATLAB. CA-Skylan-S localizations with precision
below 40 nm were used to reconstruct a 50 nm pixel size binned image. This
image was sent through a cluster finding algorithm which extracted each Gag
cluster centroid (window 150 × 150 nm) using a threshold that requires a
minimum number of localizations and integrated probability density above 1
standard deviation from the background. Single molecule localizations of Env
were then deemed proximal or distal to a Gag lattice by use of Equation (1). The
separated localizations were then linked using a previously described track
13

linking algorithm adapted to MATLAB from Crocker and Grier 1996 (Crocker and
Grier, 1996). The parameters for linking are as follows: 50 ms time gap, 10
minimum localizations per track, 1 pixel (108.33 nm) maximum frame to frame
distance. The remaining tracks were analyzed as previously described by using
the moment scaling spectrum to calculate Dapparent and SMSS (Ferrari et al., 2001;
Pezeshkian et al., 2019). Mean squared displacement (MSD) was fit to a linear
regression solving for Dapparent using the lag time, τ. MSD = 4 × Dapp × τα.
Localization uncertainties were then used to weight the MSD fits, where Ro is
displacement and σR is standard deviation: ΣσRRo × ΣRo
Monte Carlo Simulations of Single Molecule Localization and HIV-1
Assembly Site Reconstruction
Simulations were performed using custom scripts written in MATLAB.
Simulations were designed to assess the accuracy of reconstructions and
centroid finding for scenarios with differing numbers of CA-Skylan-S probes per
lattice and variances in molecular reappearance (Appendix Figure 1). CA-SkylanS molecules were semi-randomly distributed on the surface of a sphere with a
radius of 75 nm. Our simulations constrained the molecular positions to
discontinuous regions between the polar angles ( 5π/3 , π/3 ) and ( 2π/3 , 4π/3 )
to mimic the open neck of the viral bud and the increased accessibility of
equatorial CA binding sites, respectively. True molecular positions were then
shifted pseudo-randomly to mimic centroid uncertainty. This pseudo-random
displacement vector was selected from a normal distribution centered around its
position with a standard deviation of 50 nm, approximately the sum of our
14

maximum localization uncertainty and standard deviation of our localization
precision in experimental data (σmax = 40 ± 9 nm). Each simulation used a fixed
number of molecular reappearances (α = 1 to 5) resulting in total localizations (1
to 50) to assess the accuracy of reconstruction. For each condition, 50 simulated
assembly site X/Y-FWHM and centroids were averaged for each value of α.
Results
Simultaneous Superresolution Reconstruction and Tracking of HIV-1
Gag and Env
To track HIV-1 Env with respect to sites of virus assembly on the plasma
membrane of living cells, we used total internal reflection fluorescence
microscopy (TIRF-M) with simultaneous dual-wavelength monitoring. To
reconstruct sites of Gag assembly below the diffraction-limit of the light
microscope, we used a genetically encoded Camelid antibody (nanobody),
targeting the Capsid (CA) domain of Gag, fused to the photoswitchable
fluorescent protein Skylan-S (Helma et al., 2012; Zhang et al., 2015), and
expressed from the viral genome. Previously, we demonstrated that the CA
nanobody has no known perturbing effects on the formation of virus particles
(Pezeshkian et al., 2019). We screened several green photoswtichable
fluorescent protein variants from the Skylan series and selected Skylan-S
(mEOS3.1 parent with H62S mutation) as it displayed ideal photoswitching rates
and photon output for our desired frame rate. Unlike mEOS3.1, Skylan-S does
not undergo photoconversion from a green to red form (Zhang et al., 2015),
instead it transitions between ‘on’ and ‘off’ green fluorescent states (Figure 1A).
15

Specifically, these single fluorescence events are captured during high-speed
streaming and can be subsequently fit to a Gaussian function to determine the
position of the fluorescent probe.
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Figure 1. CA-Skylan-S probes accurately reconstruct HIV-1 assembly sites
on live infected T-cells. (A) The HIV-1 Gag lattice (Gray) oligomerizes on the
inner leaflet of the plasma membrane (Blue). The genetically encoded anti-CA
nanobody fused to Skylan-S (CA-Skylan-S) binds specifically to the N-terminal
domain of Capsid. Skylan-S undergoes photoswitching upon illumination with
blue (473–488 nm) laser light, moving single Skylan-S molecules between a
‘Dark’ and ‘On’ fluorescent state (black and green, respectively). (B) Example of
localization accumulations for a single diffraction-limited virus assembly site on a
live infected CEM-A cell expressing CA-Skylan-S probes. Green represents ‘On’
molecular localizations accumulated over time. Black represents the final
accumulation of localizations for the reconstructed virus assembly site. Curves
are the respective probability densities in horizontal and vertical directions (X,Y)
for the superresolution reconstruction showing a Gaussian-like distribution after
sufficient sampling of lattice-associated CA-Skylan-S probes.
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Figure 1 cont. (C) Aggregate of all uncertainties in position for each localization
in all data sets is demonstrated (σ). The histogram was fit to a bimodal Gaussian
probability density (μσlow=32.9±8.9,μσhigh=68.9±18.2 nm). The larger peak was
eliminated by filtering localizations to σ<40 nm and likely represents localization
events in areas of high cellular background. (D) Assembly sites on the surface of
live CEM-A T-cells were reconstructed using the localization centroids with their
respective uncertainties (scale: Image = 5 μm, Inset = 200 nm. Maximum
localization density: 0.7 localizations per nm2). (E) Full-width at half-maximum
(FWHM) for segmented virus assembly sites (normal distribution
fit: μXFWHM=139.8±30.5 nm; μYFWHM=137.7±31.3 nm; fit not shown). FWHM
in both coordinates converge on the theoretical size of HIV-1 particles,
demonstrating the ability of CA-Skylan-S probes to superresolve sites of virus
assembly on living infected T-cells.
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This centroid and the number of integrated photons are used to determine the
uncertainty in the position measurement (Betzig et al., 2006) (Figure 1B,C). The
accumulation of these points and their uncertainties in time enables the
reconstruction of the Gag lattice below the diffraction-limit using the live-cell
PALM method (Shroff et al., 2008) (Figure 1D and Figure S1). To determine
whether assembly sites were reconstructed to the approximate size of an HIV-1
particle in 2-D cartesian coordinates, they were fit to a normal distribution and
full-width at half maximum (FWHM) was calculated. The approximate size of the
HIV-1 virus particle is ≈ 145 nm (Briggs et al., 2003b), which validates 138 ± 31
nm as our mean FWHM of assembly sites (Figure 1E). We found that membrane
movement and microscope drift were negligible during rapid acquisition (100
frames per second (fps); 30 s interval) as FWHM reconstructions between x and
y dimensions varied by 5.8 nm (4%) for each assembly site measured (Appendix
Figure 2). Importantly, simulations of our experimental system suggest that our
FWHM reconstructions of virus assembly sites results from the localization of
more than one CA-Skylan-S molecule (Appendix Figure 3). To visualize single
Env trimers diffusing proximal and incorporating into Gag assembly sites, we
labeled Env trimers with a modified anti-Env antibody fragment (fab) conjugated
to a quantum dot. The anti-Env fab, BG18, has nanomolar affinity for the glycanV3 region of the gp120 ectodomain of Env (Freund et al., 2017). The fab was
produced recombinantly in bacteria in order to incorporate an unnatural amino
acid, p-azido-L-phenylalanine, capable of reacting site-specifically to a
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dibenzocyclooctynol (DIBO)-modified quantum dot via copper-free click
chemistry (Pezeshkian et al., 2019) (Figure 2, Appendix Figure 4).
Conjugation of the fab to Quantum Dot 625 (QD625) provided a mean
localization precision of 16.1 ± 6.6 nm at 100 fps when bound to surface-exposed
Env (Figure 2C). With high spatiotemporal resolution and sparse cellular labeling
of Env using the BG18-QD625 probe, we were able to visualize and quantify subviral confinement of Env within single reconstructed Gag lattices (Figures 1D and
2B). No significant cross-talk between the two fluorescent channels was
observed (Appendix Figure 5) and QD625 fluorescence intensity remained
relatively stable during imaging intervals (Appendix Figure 6). Env in proximity to
Gag centroids were fit to a normal distribution to asses the FWHM of
confinement. The mean FWHM of Env positional measurements within the viral
lattice was 101 ± 48 nm, corresponding to 73 percent of the average size of viral
assembly sites measured by live-cell PALM (Figure 2E).
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Figure 2. BG18-QD625 is a highly specific monovalent probe for highdensity localization of single HIV-1 Env trimers. (A) HIV-1 Env diffuses freely
on the plasma membrane until encountering a Gag lattice. BG18-QD625
(Magenta) binds to a glycopeptide (V3) on the HIV-1 Env gp120 ectodomain. The
gp120 domain non-covalently associates with the ectodomain of gp41, which is
anchored to the membrane through the transmembrane and Cytoplasmic Tail
(CT) domains, with the CT putatively interacting with or sterically trapped by the
Gag lattice. (B) Temporal point localization of a single Env trimer reconstructs a
diffusion trajectory. Magenta stars represent new localizations of a single BG18QD625 probe per frame. Black represents the entire accumulation of
localizations over the time of acquisition. Curves represent the probability
densities in horizontal and vertical (X,Y) dimensions for sub-diffraction limited
distributions of mobile trimers labeled by BG18-QD625.
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Figure 2 cont. (C) The localization precision of BG18-QD625 labeled Env
trimers is σ=16.1±6.6 nm, equating to roughly 10% of the diameter of a single
virus particle, allowing for mobility measurements at a sub-viral scale. (D)
Tracking of single Env trimers on living cells demonstrates that Env has a range
of mobility distributions. The maximum density of localizations
is 13.2 localizations per nm2 (magenta color bar) over 30 s of sampling. Inset
shows a highly confined Env trimer displaying an apparent normal distribution of
displacements (inset scale bar is 200 nm; full image scale bar is 5 μm). (E)
Single molecule trajectories of Env classified as proximal to sites of assembly
were fit to a normal curve and the FWHM was calculated (fits not shown). These
tracks proved to be highly confined at the sub-viral level
(μXFWHM=103.3±43.2nm and μYFWHM=111.0±52.2 nm). Clusters of Env
localizations were found to be 30% smaller than the average size of virus
assembly sites. This suggests that Env may be relegated to a sub-region of the
viral lattice.
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Sub-Viral Quantification of Env Diffusion
With our results suggesting that single Env trimers in proximity to the Gag
lattice have some sub-viral mobility, we then sought to quantify the differences in
mobility between Gag lattice proximal and distal Env trimers. Trimers were
deemed proximal to a Gag lattice if they were found within a radius of influence
(ROI) measured from the centroid of the Gag lattice by the following equation:
ROI = ((FWHMX2 + FWHMY2)-2 + 2σFWHM + σRegistration) / 2
where FWHM-X/-Y are the virus assembly site dimensions, σFWHM is the standard
deviation of the FWHM distribution, and σregistration is the error in alignment of
the Env and Gag fluorescent channels. In regions void of a Gag lattice ROI, Env
tracks were classified to be distal. We quantified the differences in mobility
between proximal and distal single Env trimers by first linking Env localizations
based on proximity to one another and their frame interval (see Materials and
Methods for track linking description). We observed marked differences in track
appearance and shape between proximal and distal tracks, with distal tracks
displaying random-walk or Brownian-like motion (Figure 3A). Next, we computed
the apparent diffusion coefficient (Dapparent) and slope of the moment scaling
spectrum (SMSS) for individual tracks, which mathematically describe the area
covered by a single molecule in unit time and how well the molecule samples that
area, respectively (Ferrari et al., 2001; Qian et al., 1991). There was a significant
shift in both Dapparent and SMSS between proximal and distal tracks (PDapparent =
2.67 × 10−17 , PSMSS = 1.04 × 10−15). Dapparent for proximal tracks (0.042 µm2s−1 )
was roughly 40 percent lower than for distal tracks (0.068 µm2s−1 ), indicating
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that the Gag lattice acts as a diffusion barrier for the Env trimers when
incorporated (Figure 3B-E). There was also a 70 percent reduction in SMSS for
proximal (0.028) versus distal tracks (0.099). Because the SMSS parameter
indicates the shape or trajectory of a track as it samples an area of the
membrane, a reduction in SMSS implies a more confined trajectory. An SMSS =
0.028 and Dapparent = 0.042 µm2s−1 for proximal Env concludes that the tracks are
highly confined, with sub-viral diffusion over the time frame of acquisition (≈ 30
s). Quantification of these parameters suggests that Gag has a significant
influence on Env during virus assembly compared to distal Env trimers on the
plasma membrane (Figure 3). The described methodology provides greater
precision in the measurement of the Gag lattice perimeter, thus reducing the
misclassification of proximal versus distal tracks and the associated error in
diffusion measurements. Concurrently, our optimized BG18-QD625 probe
enables tuneable high-density localization and tracking of single Env trimers on
the surface of infected cells with tens of nanometers of precision.
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Figure 3. HIV-1 Env is highly confined at sites of assembly and diffuses
freely when non-proximal to the Gag lattice on the surface of infected CEMA T-cells. (A) Representative examples of Env diffusion ‘Proximal’ and ‘Distal’ to
sites of assembly (scale bars are 200 nm; Env: time-colored gradient; Gag: gray
localization density). When proximal, Env was never observed to escape the Gag
lattice over the sampling period, yet is able to freely diffuse when distal to
assembly sites. Width of points represent uncertainty in localization of a single
molecule in the time-series.
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Figure 3 cont. (B) Histograms of the apparent diffusion coefficient (Dapparent)
for proximal and distal tracks in log10 scale (Dapparent=0.04±0.02 μm2×
s−1 and 0.07±0.04 μm2×s−1, respectively). (C) Histograms of the slope of the
moment scaling spectrum (SMSS) for proximal and distal tracks
(SMSS=0.03±0.13 and 0.10±0.02, respectively). (D,E) Dapparent and SMSS for
proximal versus distal trajectories were found to be statistically significant with a
respective increase in both parameters for distal trajectories suggesting that Env
trimers are less mobile and more sub-diffusive when proximal to a Gag lattice.
Significance was assessed using a two-tailed unpaired t-test
(PDapparent=2.67×10−17; PSMSS=1.04×10−15; α=0.0001; NProximal=476, NDi
stal=4089). Error bars represent standard deviation.
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Discussion
Many aspects of virus biogenesis remain enigmatic due to our inability to
resolve the time-variant structural organization of viral sub-assemblies while
simultaneously maintaining molecular specificity and physiologically relevant
conditions. Time-resolved superresolution approaches, however, offer promise to
further our understanding of the molecular steps and sequences of events that
transpire during virus assembly. In this study, we present a method for sub-viral
quantification of biophysical interactions between single molecules of HIV-1
envelope glycoproteins and the structural Gag lattice using live-cell single particle
tracking and superresolution microscopy, respectively. This approach has
allowed us to visualize nanoscale interactions between these molecules during
virus biogenesis on the host-cell plasma membrane. We have shown that Gag
lattices can be reconstructed to expected virus dimensions, below the diffractionlimit of the light microscope, using live-cell PALM. Further, we show that Env
trimers can be simultaneously tracked and quantified based on their precise
proximity to superresolved virus assembly sites. Our approach has relied on the
use of a genetically-encoded cytoplasmically-expressed nanobody fused to a
reversibly switchable fluorescent protein to reconstruct virus assembly sites. The
success of live-cell PALM is highly dependent on how well the sub-diffractive
object is decorated with a fluorescent probe. We show that the CA-Skylan-S
nanobody probe sufficiently samples the Gag molecules in a single virus
assembly site because each superresolved image over a 30 s time course yields
a FWHM approximately the size of expected virus assembly sites measured by
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electron microscopy (Briggs et al., 2003b). The success of live-cell PALM
imaging additionally requires sufficient sampling of each fluorescent probe within
the structure of interest and high molecular brightness to reduce the uncertainty
in the position of each probe. We judiciously selected the Skylan-S reversiblyswitchable green fluorescent protein for its single molecule brightness and
switching frequency. Skylan-S enabled us to sufficiently sample each nanobody
tagged probe a few times before bleaching irreversibly, while also giving a
sufficiently high photon count for each frame to more precisely localize single
molecule probes. Our attempts with other variants of the Skylan series of
reversibly-switchable green fluorescent proteins resulted in either low molecular
brightness and poor localization precision or poor switching properties resulting
in a lack of blinking and single molecule detection (data not shown). Finally, livecell superresolution reconstructions require careful consideration of physical
displacements of the object of interest, requiring tuning of sampling conditions to
reduce motion blur artifacts (Huang et al., 2013; Shroff et al., 2008). In the case
of HIV-1 Gag lattice formation, this structure remains sufficiently static over the
sampling period (30 s) as evidenced by the FWHM reconstructions and expected
diameters of HIV-1 particles. Using our optimized fluorescent label and sampling
conditions, we still, with minor frequency, found that our software filters out what
is likely an assembly site that cannot be properly fit due to lack of localizations.
Insufficient sampling at putative virus assembly sites, due to poor CA-Skylan-S
probe labeling or sampling, may contribute to erroneous classifications of Env,
resulting in an increase in apparent diffusion coefficient and SMSS distribution
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error. The sparsity of Env labeling with our methodology, however, statistically
reduces the frequency of these false-negative events. Additional considerations
for implementation of this methodology are the production of a recombinant
antibody fragment, subsequent site-specific unnatural amino acid modification
and copper-free click chemistry to a quantum dot (Appendix Figure 3 and
Materials and Methods). While unnatural amino acid constructs are publicly
accessible and quantum dot kits are commercially available, production of the
probe in usable quantities can be costly and technical for adopters without
recombinant protein chemistry experience. The BG18-QD625 probe described
here is a prime example of a highly optimized recombinant protein expression
protocol and tuned conjugation chemistry, which yields large quantities of stable
probe that can be used for months to years. Ultimately, live-cell superresolution
and SPT methodology requires highly specific and high affinity (sub-10 nM
dissociation constant) monovalent reagents for labeling of biological structures of
interest due to the intrinsic single molecule sensitivity of these experiments. The
optimization of the CA-Skylan-S probe has provided a means for precise
superresolution reconstructions of single HIV-1 assembly sites on the surface of
live infected T-cells. Importantly, this resolution improvement has the potential to
measure minor perturbations to Env mobility during lattice trapping. Further, our
optimized production and validation of the BG18-QD625 probe has enabled us to
tune the density of labeled Env trimers to maximize data collection on a per cell
basis. This methodological advancement has provided insight into the
biophysical interactions between the critical vaccine target HIV-1 Env and the
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underlying Gag lattice that coalesce to create an infectious virus particle. The
sub-diffusive nature of Env in the Gag lattice could indicate a direct interaction
between the membrane proximal matrix (MA) domain of Gag and the cytoplasmic
tail of Env (Env-CT). We cannot rule out a physical or steric corralling
mechanism, however, which creates a diffusion barrier to trap Env in a subdiffusive state within the lattice. Further work will be aimed at elucidating potential
molecular interactions using the methodology we have presented. Studies
investigating diffusional behaviors of viral envelope glycoproteins with their
respective structural components should lead to discovery of new therapeutic
approaches that target virus assembly.
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Chapter 3: Chimeric Envelope monomers are trapped in the HIV-1 Gag
lattice and inhibit native Envelope glycoprotein incorporation
Introduction
During HIV-1 assembly, the trimeric viral spike, Env, and the viral core
protein, Gag, are biosynthesized and trafficked to the plasma membrane through
two independent pathways. Upon reaching the plasma membrane, Gag
assembles into a lattice that deforms the membrane into a bud with outward
curvature (Briggs et al., 2003; Jouvenet et al., 2008). Env is co-translationally
folded into the endoplasmic reticulum, oligomerizing and trafficking through the
secretory pathway to the plasma membrane where it then diffuses on the surface
until encountering a Gag lattice (Fuller et al., 1997; Jouvenet et al., 2008; Alfadhli
et al., 2009; Muranyi et al., 2013; Hendrix et al., 2015; Sakin et al., 2017; Buttler
et al., 2018). We have previously observed the trapping of native Env trimers at
HIV-1 assembly sites and their confinement to a sub-viral region on the virus bud
(Pezeshkian, et al., 2019; Groves et al., 2020), indicating that Env is retained in
the Gag lattice through either a direct interaction or lattice corralling, as has been
suggested previously (Alfadhli et al., 2009; Chojnacki et al., 2012; Buttler et al.,
2018; Alfadhli et al., 2019). We observed that this lattice confinement is
dependent on the Env-CT and Gag MA domains, however, the conformational
and oligomeric states required for lattice trapping of Env remain uncertain.
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The HIV-1 Env ectodomain functions as a trimer to mediate virus
membrane fusion with a naïve target cell (Munro et al., 2014; Gardiner et al,
2016; Ma et al., 20 18). It has also been shown that the Env-CT can influence the
ectodomain conformation and fusogenicity of Env, suggesting that the
conformations of the Env-CT may act as a molecular switch to regulate Env
function (Durham and Chen, 2015; Gardiner et al., 2016). The first in vitro
solution structure of the Env-CT, in the absence of the transmembrane domain,
depicted a relatively linear conformation with amphipathic α-helical secondary
structure embedded in a liposomal membrane (Murphy et al., 2017). Recently, an
additional solution structure of the Env transmembrane domain (TMD) and the
CT demonstrated that the Env-CT, when trimerized by the TMD, can form a
spiral-like ternary complex that was termed a ‘baseplate’ (Piai et al., 2021). This
study demonstrated that perturbations to the quaternary baseplate structure can
influence ectodomain conformations. Collectively, these observations suggest
that the Env-CT may undergo conformational changes between linear and
quaternary structures at different stages of the infection cycle. Herein, we aimed
to address whether the quaternary structure of the Env-CT is also necessary for
Env incorporation in the assembling virus.
Materials and Methods
Plasmid production
The monomeric 318KE mutant human CD4 isoform 1 ecto and
transmembrane domain was created as a synthetic human codon optimized
gBlock (IDT). The synthetic construct included the entire CD4 ecto and
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transmembrane domain up to residue 420V and was assembled into the pLJM1
lentiviral transfer plasmid for eukaryotic expression using the AgeI and EcoRI
restriction sites (pLJM1-EGFP was a gift from David Sabatini, Addgene plasmid
19319) (Sancak et al., 2008). The NL4-3 712YA mutant Env-CT, beginning at
residues 707R after the transmembrane domain, was fused to the CD4 TMD at
the C-terminus to make mCD4-EnvCT. The mCD4-ΔCT construct was designed
with the short C -terminal tail – GSWPAS (Pham et al., 2004)(Figure 4A). The
HIV-1 pSV-NL4-3 plasmids were designed as previously described (Groves, et
al., 2020). Briefly, the NL4–3 reference genome was cloned into an SV40 oricontaining backbone (pN1 vector; Clontech/Takara Bio USA). For chimera
incorporation, the NL4-3 plasmids were modified by removal of the BclI-NsiI and
NsiI-BglII fragments to delete pol and env, respectively. For competition
experiments with Env(+) VLPs, 712YA env was produced by site-directed
mutagenesis in a shuttle plasmid and was ligated into the NL4-3 backbone using
the EcoRI and XhoI sites (Pezeshkian, et al., 2019). For all imaging experiments,
the NL4-3 genome was modified to prevent virus particle release by mutation of
the 455-458 PTAP to LIRL, and deleted for vif/vpr by removal of the AflII-AflII
fragment. All constructs were additionally modified to include the CA-SklylanS
fusion in the nef splice site (Buttler et al., 2018; Hoffman et al., 2019;
Pezeshkian, et al., 2019; Groves, et al., 2020). MA mutations were introduced by
site-directed mutagenesis at residues 12L and 34V in a shuttle containing the
AatII-SpeI fragment of gag. The fragment was then ligated into the expression
plasmid at these sites. The HA-Halo-gt constructs were designed by linking the
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signal peptide (SP) of CD4 to the N-terminus of HA, the C-terminus of SP-HA
was fused to the N-terminus of Halo Tag, the C-terminus of Halo Tag to a linker
and N-linked glycosylation site (LNGSKLQRPHQALGDVAGRGNEKKPSSVR),
and then the N-terminus of the LDL receptor transmembrane domain:
ALSIVLPIVLLVFLCLGVFLLW. The gene cassette was codon optimized for
mammalian expression and synthesized as a gBlock (IDT). The cassette was
then inserted into the pLJM1 lentiviral transfer plasmid at AgeI and EcoRI
restriction sites. The 712YA Env CT was introduced as a C-terminal fusion at
residues 707R to make a monomeric Env-CT. The truncated Env-CT (ΔCT) was
created with only the short anti-EnvCT Chessie 8 epitope (Abacioglu et al., 1994)
(GSSPDRPEG) fused to the end of the transmembrane domain.
Cells and cell culture conditions
The A2.01 CD4(-) and A3.01 T-cell lines were acquired through the AIDS
Reagent Program, Division of AIDS, NIAID, NIH and provided by Dr. Thomas
Folks (ARP 2059 and ARP 166, respectively) (Buttke and Folks, 1992; Folks et
al., 1985) and cultured in RPMI (#17-105-CV) medium supplemented with 2 mM
L-glutamine (#25-005-CI; Corning), 1× penicillin-streptomycin (#30-003-CI;
Corning), 1× hypoxanthine (25-047-CI; Corning), and 10% fetal bovine serum
(FBS, #35-011-CV; Corning). A2.01 cells were transduced with pLJM1-mCD4EnvCT/-ΔCT-derived lentivirus (see Virus production section below) and selected
for with 1 µg×mL-1 puromycin 48 hours post infection. After 1 week, single cells
were isolated and expanded. COS7 (CRL-1651) and HEK293T (CRL-3216) cells
were acquired through ATCC (Manassas, VA) and cultured at 37°C with 5% CO2
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in complete DMEM supplemented with 2 mM L-glutamine (#25-005-CI; Corning),
1x penicillin-streptomycin (#30-003-CI; Corning), and 10% FBS (#35-011-CV;
Corning). COS7 cells were selected for transduction with 1 µg×mL-1 puromycin
for 1 week and cultivated in bulk as all cells were confirmed to express and
display mCD4 chimeras.
Virus production
Replication incompetent lentivirus for both modified NL4-3 and mCD4
chimera containing constructs were produced through co-transfection of
HEK293T with psPAX2 (Addgene, plasmid #12260) and pVSV-G (a gift from Dr.
Xuedong Liu, University of Colorado, Boulder) plasmids with polyethyleneimine
as previously described (Pezeshkian, et al., 2019). Lentivirus was harvested 48
hours post transfection and 0.45 µm filtered. For competitive inhibition
experiments, HEK293T cells were transfected with both NL4-3 Env 712YA and
HA-Halo-gt-EnvCT chimera plasmids. Cell and supernatant fractions were
harvested 48 hours post transfection.
Western Blotting
Incorporation assays were performed by single-round infection of A2.01mCD4 cells. Supernatant from A2.01 infection or HEK293T transfections were
harvested 48 hrs post-transduction and -transfection, respectively, and clarified
by 15,000 × g centrifugation. Virus-like particle fractions were isolated from
clarified supernatant by ultracentrifugation at >100,000 × g over a 20% sucrose
cushion using a Beckman SW-41ti rotor. Virus particle pellets were resuspended
in phosphate-buffered saline (PBS). Cells were lysed with RIPA buffer (50 mM
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Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA; SigmaAldrich)
supplemented with protease inhibitor cocktail (#S8830, Sigma-Aldrich). Cell
lysates were clarified by centrifugation at 15,000 × g for 5 minutes. All samples
were loaded onto SDS-PAGE 4-20% gradient gels (Bio-Rad, catalog no.
4568096) and transferred to PVDF membrane. Membranes were blocked in
PBST-M (PBS pH 7.4, 0.1% Tween-20, 5% non-fat milk w/v) before primary
staining under the conditions described below. After probing, membranes were
washed thrice with PBST. Membranes requiring secondary stain were incubated
in 5% PBST-M with secondary for 1 hour at room temperature and washed thrice
with PBST. Membranes labeled with secondary horse-radish peroxidase (HRP)
conjugated antibodies were incubated in Pico Plus ECL (#20-302, Genesee
Scientific). Both HRP and fluorescence were detected using a Protein Simple
imager (Protein Simple). The following antibody conditions were used in 5%
PBST-M: anti-CD4 (Abcam, ab133616) – 1:5,000 overnight 4°C; anti-p24 –
1:1,000 room temperature 1 hour; anti-gp41 – 1:1,000 overnight 4°C; anti-gp41
(10e8v4) – 1:1,000 overnight 4°C; anti-alpha-Tubulin (clone B-5-1-2, #T5168,
Sigma-Aldrich) – 1:5,000 1 hour room temperature; anti-Mouse HRP (#31430,
Thermo Fisher) – 1:10,000 1 hour room temperature; anti-Rabbit HRP (Jackson
Immuno Research, AB_2307391) – 1:5,000 1 hour room temperature; Goat antihuman HRP (#62-8420, Invitrogen) – 1:5,000 1 hour room temperature; anti-HA
(Roche) – 1:5,000 overnight 4°C. The anti-HIV-1 p24 monoclonal IgG was
obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH
from Dr. Bruce Chesebro and Kathy Wehrly (#6457) (Toohey et al., 1995; Wehrly
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and Chesebro, 1997). The polyclonal Anti-Human Immunodeficiency Virus
Immune Globulin was obtained through NIH AIDS Reagent Program, Division of
AIDS, NIAID, NIH from Dr. Luiz Barbosa. The anti-HIV-1 gp41 10E8v4
monoclonal IgG was obtained through the NIH AIDS Reagent Program, Division
of AIDS, NIAID, NIH from Dr. Peter Kwon (#12865) (Kwon et al., 2016). The antiHIV-1 gp41 2F5 monoclonal IgG was obtained through the NIH AIDS Reagent
Program, Division of AIDS, NIAID, NIH (#ARP-1475). Chessie 8 was obtained
through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH from Dr.
George Lewis (ARP-13049) (Abacioglu et al., 1994). Densitometry was
performed using ImageJ (FIJI) and analyzed in Matlab (Mathworks). The dose
response curve for the competitive inhibition assay (Fig. 7E) was generated
using a sigmoidal fit of the mean normalized gp41/Pr55 densities with respect to
the log10-transformed molar ratios of HA-Halo-gt-EnvCT to Env 712YA (WT). IC50
was determined to be the molar ratio at which normalized gp41/Pr55 decreases
by one half.
Membrane Stripping
Membrane stripping assay was performed as previously described with some
modifications (Kiernan, et al., 1999). HEK293T cells were co-transfected with
pNL4-3 pol(-) env(-) and pLJM1-mCD4-EnvCT or pLJM1-mCD4-ΔCT using
Lipofectamine 2000 (Invitrogen). Virus was harvested 48 hours post transfection
and filtered through 0.45 µm membrane. Virus was incubated with either 0.05%
NP-40 for HIV-1 Env trimers and 0.075% NP-40 for mCD4 chimeras or PBS for
15 minutes at 25°C and then sedimented in a 20% sucrose cushion. Virus was
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harvested at 60,000 × g at 4°C for 1 hour. The level of virion-associated gp41,
mCD4-EnvCT, Pr55 in the pellets was determined by western blotting using antiEnv (10E8v4/2F5), anti-CD4 Ab (ab133616), and HIV-Ig (Gag detection),
respectively.
Imaging probes
Mouse IgG1 anti-human CD4 clone SFCI12T3D11 (Beckman) was digested
into Fab-fragments using the papain proteolysis kit (#44985, Thermo Scientific).
The purified Fabs were labeled with NHS-PEG4-Azide (#26130, Thermo
Scientific) using a 1:1 molar ratio, free NHS-PEG4-Azide was removed using a
7K MWCO Zeba filter (#89883, Thermo Scientific), and Fab-PEG4-Azide was
subsequently conjugated to the DBCO-QD625 quantum dot probe using copperfree click chemistry (Site-Click QD625 kit #S10452, Thermo Scientific). The
resulting anti-CD4-QD625 fab conjugates were then purified from QD625 using
CaptureSelect LC-kappa (murine) Affinity Matrix (#191315005, Thermo
Scientific). Unconjugated anti-CD4 Fabs were removed using a 100 KDa MWCO
protein concentrator (Site-Click kit) and anti-CD4-QD625 conjugates were
concentrated to ~10 µM. The anti-gp120 HIV-1 Env BG18-QD625 was produced
as previously described (Groves, et al., 2020). Briefly, p-azido-L-phenylalanine
modified BG18 Fab was recombinantly produced in E. Coli by co-expression with
an unnatural amino acid incorporation system (Chin et al., 2002). The fab was
purified by multiple affinity resin matrices then conjugated to DIBO modified
quantum dots using a site-specific copper-free click reaction (Site-Click QD625
kit). The conjugated fabs were further purified using a final CaptureSelect CH138

XL affinity matrix (#19434620, Thermo Scientific). The genetically encoded CASkylanS probe, an anti-CA camelid nanobody fragment fused to the reversibly
switchable green fluorescent protein Skylan-S (Zhang et al., 2015), was designed
and expressed from the NL4-3 proviral genome as previously described (Groves
et al, 2020).
Fluorescence microscopy imaging conditions
COS7 cells were blocked in complete media supplemented with 10% BSA for
30 min at 37°C and 5% CO2. Cells were stained at room temperature with antiCD4-QD625 or BG18-QD625 at typically 10 nM final concentrations,
respectively. Cells were washed with complete media thrice in intervals of 5
minutes. Cells were equilibrated at 37°C and 5% CO2 during image acquisition.
High-speed acquisitions were streamed on a custom-built TIRF-M with isotropic
field illumination as previously described (Groves et al., 2020). Briefly, images
were acquired at 100 Hz using 50 mW of 473 nm laser power for fluorescence
excitation (rear aperture) and images were collected using a 1.49 NA Nikon TIRF
objective and Orca-Fusion Scientific-CMOS using standard scan mode (C1444020UP Hamamatsu; Hamamatsu, Japan). The CA-SkylanS and QD625 probes
were detected simultaneously by splitting the component channels onto two
halves of the camera using a W-View Gemini image splitting mount (A12801-01
Hamamatsu).
Single-molecule tracking analysis
Analysis of tracking data was performed using custom Matlab (Mathworks)
scripts as previously described (Groves, et al., 2020). Briefly, single-molecule
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localizations and their precisions were determined using code modified from
PeakSelector (https://github.com/gleb-shtengel/PeakSelector). Localizations from
the respective CA-SkylanS and QD625 fluorescent channels were corrected for
sub-pixel chromatic aberration using 100 nm fluorescent fiducials (TetraSpeck,
T729, Thermo Fisher Scientific) to register the channels for distance
measurements between Gag assembly sites and single-molecule tracks. To
determine the centroid of a single virus assembly site, CA-SkylanS localizations
with positional uncertainty below 40 nm were binned into 50 nm pixels to
generate a low-resolution probability density map (mean localization precision for
CA-SkylanS σ=30±7 nm) . From this map, centroids were extracted based on
maximum local intensity. Bona-fide Gag buds were determined to have a
minimum of 10 localizations and a < 200 nm full-width at half maximum of binned
localization positions. Centroids without these characteristics were excluded from
analysis. Localizations of quantum dots (average localization precision of σ=11±4
nm) were passed to a custom software package written in Matlab for track linking
(Crocker and Grier, 1996) and tracks were sorted by their proximity to Gag lattice
centroids (Radius of influence = 125 nm, 10% of track localizations allowance
outside the radius). Tracks determined to be proximal to virus assembly sites
were then analyzed to compute mean squared displacement and the moment
scaling spectrum previously described (Ferrari et al, 2001; Pezeshkian et al,
2019; Groves et al, 2020). Track diffusion coefficients and SMSS were pooled for
statistical analysis using the inbuilt ttest2 function in Matlab for log10(Dapp) and
SMSS individually. The mean and associated error were extracted for log10(Dapp)
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and SMSS diffusion parameters by fitting to normal distributions. The approximate
full-width at half maximum (FWHM) estimates of probe displacements in the X
and Y dimensions were extracted by first fitting individual tracks to normal
distributions and subsequently calculating FWHM=2.355×σ, where σ is the
standard deviation parameter extracted from the normal distribution fit. The X
and Y FWHM estimates were averaged to generate one-dimensional histograms
that were fit to lognormal distributions to extract mean and standard deviation.
Results
Monomeric HIV-1 Env-CT chimeras are incorporated into virus particles
in an Env-CT dependent manner
To further understand the relationship between the Env-CT structure and
Gag lattice retention, we sought to determine whether a synthetic monomeric
Env-CT, incapable of forming a quaternary baseplate structure, was sufficient for
incorporation at virus assembly sites. To accomplish this, we generated A2.01 Tcell (CD4-null) (Bedinger et al., 1988) and COS7 cell lines stably expressing
chimeras between the host-cell derived ecto- and transmembrane domains of
CD4 fused to the Env-CT. CD4 is biosynthesized and functions as a monomeric
type-I transmembrane protein but has the potential to oligomerize on the plasma
membrane (Moldovan et al., 2002). To eliminate oligomerization potential of the
CD4-EnvCT chimeras, we introduced a previously validated mutation, 318KE,
into the CD4 ectodomain to produce monomeric CD4 (mCD4) (Byland et al.,
2007). We additionally introduced the 712YA mutation into the Env-CT to
increase surface expression on the plasma membrane (Pezeshkian et al, 2019).
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We have previously shown that this residue is not required for lattice trapping
(Pezeshkian et al., 2019). An Env-CT null (mCD4-ΔCT) version of the chimera
was generated to provide a control for any possible CD4 transmembrane domain
interactions with virus assembly sites (Figure 4A). To confirm that no oligomeric
states existed on the surface of A2.01 cells expressing the mCD4-EnvCT
chimeras, we performed biochemical crosslinking using
bis(sulfosuccinimidyl)suberate (BS3) and compared this result to the parental
A3.01 cell line that expresses native CD4. We observed no crosslinked products
in the mCD4-EnvCT stable cell lines, while crosslinking of A3.01 cells produced a
higher molecular weight CD4 product (Appendix Figure 7), suggesting that
chimeric mCD4-EnvCT resides on the plasma membrane predominantly in a
monomeric state. To determine whether mCD4-EnvCT could be enriched in
virus-like particles (VLPs), in an Env-CT-dependent manner, we transduced
A2.01 mCD4-EnvCT and -ΔCT stable cell lines with VSV-G pseudotyped HIV-1
NL4-3 pol(-), env(-) lentivirus. VLPs produced by A2.01 cells stably expressing
either mCD4-EnvCT or mCD4-ΔCT showed significantly higher incorporation of
the Env-CT containing chimera (mCD4-EnvCT/mCD4-dCT = 16.7), indicating an
incorporation preference for Env-CT containing monomers at virus assembly
sites (Figure 4B). While these results suggest that there is an Env-CT
dependence for the mCD4-EnvCT chimera-expressing cell lines, we speculated
that it was possible that the chimera dwells in the lattice long enough to become
passively incorporated through a weak or non-specific interaction with the viral
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membrane (Briggs et al., 2003; Ono and Freed, 2005; Brügger et al., 2006;
Chojnacki et al., 2017; Alfadhli et al., 2019; Nieto-Garai et al., 2021).
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Figure 4. Monomeric HIV-1 Env-CT chimeras are incorporated into virus
particles in an Env-CT dependent manner. A. Genetic design of a monomeric
CD4-EnvCT 712YA chimera and representative structure (Env-CT: PDBID:
5VWL, CD4: PDBID:1WIP).
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Figure 4 cont. B. HIV-1 particle incorporation of stably expressed mCD4-EnvCT
in the A2.01 T-cell line is strongly dependent on the Env-CT, suggesting that a
monomeric Env-CT is sufficient for Gag-lattice enrichment. (mCD4-EnvCT
/mCD4-∆CT = 16.7 fold).
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A monomeric Env-CT chimera is retained in the immature HIV-1 Gag
lattice
Previous work has suggested that cellular host proteins and lipids may
contribute to HIV-1 virion assembly, however, in vitro studies have provided
evidence for a MA and Env-CT interaction in the absence of other protein and
lipid influences (Orentas and Hildreth, 1993; Ono and Freed, 2005; Brügger et
al., 2006; Alfadhli et al., 2009; Thali, 2009; Bauby et al., 2010; Chojnacki et al.,
2017; Alfadhli et al., 2019; Nieto-Garai et al., 2021). To test if our mCD4-EnvCT
chimeras require the immature Gag lattice for virus retention, we isolated mCD4EnvCT and mCD4-∆CT VLPs from HEK293T expressing cells and performed
detergent stripping assays. This previously described method has shown that
native HIV-1 Env co-sediments with the Gag lattice of immature VLPs, in an EnvCT-dependent manner, after NP-40 detergent striping of the virus membrane
(Wyma et al., 2000). We observed co-sedimentation of mCD4-EnvCT, similar to
WT Env (Figures 2A and 2B). Both Env-ΔCT and mCD4-ΔCT were significantly
depleted from virus particles when treated with NP-40 (Figures 5A and 5B).
These findings demonstrate that a monomeric Env-CT is sufficient for retention in
the immature Gag lattice upon disruption of the lipid membrane.
Next, we aimed to observe and compare the dynamics of single Env
trimers and mCD4-EnvCT chimeras at virus assembly sites on live infected cells.
We and others have previously demonstrated that Env is confined to sub-100 nm
regions at virus assembly sites on the plasma membrane (Chojnacki et al., 2012,
2017; Buttler et al., 2018; Pezeshkian et al. , 2019; Groves et al., 2020). The
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relegation of Env to sub-viral regions suggests the existence of a strong and
localized retention mechanism between the MA lattice and the membraneproximal Env-CT. To test if a single Env-CT is sufficient for sub-viral confinement,
we performed single-molecule tracking of stably expressed mCD4-EnvCT in HIV1 transduced (env(-)) COS7 cells and compared the diffusion behaviors to native
Env trimers at virus assembly sites. We observed that mCD4-EnvCT and native
Env trimers displayed similar confinement and retention at virus assembly sites
(Figure 5C). The apparent 2-dimensional diffusion coefficient (Dapp) of mCD4EnvCT trajectories (Dapp=0.022 ± 5.7×10-4 μm2s-1) was slightly lower than that of
WT Env (Dapp=0.027 ± 1.9×10-4 μm2s-1) at assembly sites (PDapp = 2×10-4).
Further, the slope of the moment scaling spectrum (SMSS), a measure of the
frequency of sampling the positions within a given area, was higher for mCD4EnvCT trajectories (SMSS = 0.12 ± 0.18) when compared to WT Env (SMSS = 0.056
± 0.16), suggesting that, while highly confined to a sub-viral region, the monomer
may have more freedom of movement within this region of the MA lattice
compared to a trimeric Env-CT (PSMSS = 1×10-4). To then test whether the subviral confinement of mCD4-EnvCT molecules is dependent on the Env-CT, we
performed single-molecule tracking of stably expressed mCD4-EnvΔCT on the
surface of HIV-1 transduced (pol(-)/env(-)) COS7 cells. We observed mCD4EnvΔCT trajectories with increased Dapp (0.044 ± 1.6×10-3 μm2s-1) and SMSS (0.22
± 0.22) compared with mCD4-EnvCT, indicating that mCD4-EnvΔCT freely
diffuses through Gag lattices (PDapp=1×10-4, PSMSS=1×10-4). To quantify the
degree of lattice confinement for mCD4-EnvCT versus WT Env using an
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orthogonal analysis method, we measured the full-width at half maximum
(FWHM) of all single-molecule trajectory positions residing within assembly sites.
Both mCD4-EnvCT and WT Env displayed similar FWHM values (Appendix
Figures 8A and 8B). These results collectively suggest that, similar to native Env
trimers, a monomeric Env-CT is sufficient to sense and become trapped in the
underlying Gag lattice.
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Figure 5. A monomeric Env-CT chimera is retained in the immature HIV-1
Gag lattice. A,B. Virus membranes were perturbed using NP-40 detergent. WT
Env is shown to co-sediment with Gag (Pr55) after detergent treatment, whereas
Env-ΔCT trimers are stripped from immature VLPs (A)(P=0.025, n=4). Similarly,
mCD4-EnvCT monomers co-sediment with Gag while mCD4-ΔCT is largely
stripped from immature VLPs (B)(P=0.0066, n=4).
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Figure 5 cont. C. Time projections of individual single-particle tracks (color bar)
proximal to superresolved HIV-1 assembly sites (gray). Individual tracks display
confined or Brownian mobility dependent on the presence or absence of an EnvCT, respectively (scale bars = 200nm, insets = 50nm). Gray scale bars indicate
localization (loc) density over the time of acquisition and color bars indicate
particle position over the observation period. Confined tracks (mCD4-EnvCT, WT
Env) appear white and are centered in the insets. Scatter histograms of diffusion
parameters: Dapp and SMSS for WT Env and chimera monomers with respect to
WT Gag lattice assembly sites indicate a significant shift in mobility for mCD4ΔCT as compared to mCD4-EnvCT and WT Env (mCD4-EnvCT: Dapp=0.022 ±
5.7×10-4 μm2s-1, SMSS = 0.12 ± 0.18; mCD4-ΔCT: Dapp=0.044 ± 1.6×10-3 μm2s-1,
SMSS=0.22 ± 0.22; WT Env: Dapp=0.027 ± 1.9×10-4 μm2s-1, SMSS = 0.056 ± 0.16;
mCD4-EnvCT, WT Env: PDapp= 0.0002, PSMSS=0.0001). Red dashed line, SMSS >
0.17, indicates Brownian motion. Black dashed line represents mean Dapp for WT
Env. All error represents SD.
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A monomeric Env-CT is sensitive to perturbations of the Gag MA lattice
Next, we aimed to determine whether the chimeric Env-CT monomer
exhibits a dependence on MA, as has been shown for native Env trimers (Freed
and Martin, 1995; Murakami and Freed, 2000; Alfadhli et al., 2009; Alfadhli et al.,
2019; Pezeshkian et al., 2019). To examine this, we introduced the MA-12LE
mutation into our HIV-1 pol(-)/env(-) clone; this mutation abolishes Env
incorporation and virus infectivity in the context of the fully infectious provirus, but
does not influence virus particle assembly(Freed and Martin, 1996). Incorporation
of the mCD4-EnvCT chimera into the Gag lattice was markedly diminished by the
MA-12LE mutation (Figure 6A), whereas the low levels of mCD4-EnvΔCT
passively incorporated into released particles were insensitive to the MA
mutation (Figure 6B). Next, we attempted to rescue incorporation of the mCD4EnvCT chimera into MA-12LE particles by introducing the previously described
34VI mutation, known to rescue WT Env incorporation (Murakami and Freed,
2000). Surprisingly, incorporation of mCD4-EnvCT into virus particles containing
the MA-12LE mutation could not be rescued by introduction of the MA-34VI
mutation (Figure 6A). As expected, mCD4-ΔCT incorporation was unaffected by
the MA mutations (Figure 6B). Together, these findings suggest that a single
Env-CT is sufficient for virus particle incorporation in both a CT- and MAdependent manner.
To better understand the mechanistic basis for MA dependence of the
mCD4-EnvCT chimera, we examined its diffusion behavior when in proximity to
mutant MA-12LE virus assembly sites. Consistent with our previous study
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(Pezeshkian et al., 2019), WT Env trimers can diffuse through the MA-12LE
lattice, avoiding the apparent confinement forces that lead to incorporation
(Dapp=0.043 ± 3.9×10-4 μm2s-1, SMSS=0.067 ± 0.12) (Figures 6C-6E). We and
others have suggested that this lack of confinement and incorporation in the MA12LE lattice is mechanistically linked to a rearrangement of the MA lattice
architecture (Alfadhli et al., 2009; Pezeshkian et al., 2019; Eastep et al., 2021).
Notably, mCD4-EnvCT proximal to sites of MA-12LE assembly displayed an
increase in mobility, similar to WT Env (Dapp=0.049 ± 1.3×10-3 μm2s-1, SMSS=0.15
± 0.19) (Figures 6C-6E), indicating that the MA-12L residue contributes to
confinement of monomeric Env-CTs (PDapp=1.1×10-3, PSMSS=1×10-4).
Next, we sought to determine why the 34VI rescue mutation was unable to
facilitate incorporation of mCD4-EnvCT using single-molecule tracking at virus
assembly sites. We observed that MA-34VI restores confinement for Env trimers
at MA-12LE virus assembly sites (Dapp = 0.029 ± 6.2×10-4 μm2s-1, SMSS = 0.058 ±
0.14); however, mCD4-EnvCT showed elevated mobility and sampling of lattice
positions in the presence of this rescue mutation (Dapp=0.056 ± 1.4×10-4 μm2s-1,
SMSS=0.14 ± 0.17) (Figures 6C, 6D, and 6F). This result suggests that a trimerspecific lattice retention mechanism was selected for with the MA-34VI rescue
(Freed and Martin, 1996; Murakami and Freed, 2000). Given the recent structure
of the ordered trimeric Env-TMD and -CT (Piai et al., 2021), our results suggest
that the Env-CT baseplate is not important for Env retention in the WT MA lattice;
however, compensatory mutations such as 34VI may recognize quaternary
structural features in the baseplate.
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Figure 6. A monomeric Env-CT is sensitive to perturbations of the Gag MA
lattice. A. The 12LE and 12LE/34VI MA lattice are defective for mCD4-EnvCT
incorporation. B. mCD4-∆CT is insensitive to the 12LE and 12LE/34VI MA
mutant lattice and passively incorporates regardless of the MA genotype.
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Figure 6 cont. C. Representative time projections of single molecule trajectories
for WT Env and mCD4-EnvCT diffusion in 12LE and 12LE/34VI MA lattices.
Scale bars=200 nm, inset=50 nm.
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Figure 6 cont. D. (mCD4-EnvCT: Dapp=0.049 ± 1.3×10-3 μm2s-1, SMSS=0.15 ±
0.19; WT Env: Dapp=0.043 ± 3.9×10-4 μm2s-1, SMSS=0.067 ± 0.12, PDapp=1.1×10-3,
PSMSS=3.5x10-8). D. Diffusion in 12LE/34VI lattices (mCD4-EnvCT: Dapp=0.056 ±
1.4×10-3 μm2s-1, SMSS=0.14 ± 0.17; WT Env: Dapp = 0.029 ± 6.2×10-4 μm2s-1, SMSS
= 0.058 ± 0.14, PDapp=3.6x10-17, PSMSS=7.5x10-5) (top panel), Apparent diffusion
coefficients for WT Env (top panel) and mCD4-EnvCT monomer (bottom panel)
for all virus assembly sites measured. WT Env confinement is defective in the
12LE MA lattice, however, WT Env becomes diffusionally confined with the
12LE/34VI MA lattice rescue mutation (WT, 12LE: PDapp=2.9x10-23; 12LE,
12LE/34VI: PDapp=3.6x10-17; WT, 12LE/34VI: PDapp=0.16). Diffusional
confinement is not rescued in the 12LE/34VI lattice for mCD4-EnvCT monomers
(WT, 12LE: PDapp=3.7x10-15; 12LE, 12LE/34VI: PDapp=0.14; WT, 12LE/34VI:
PDapp=8.5x10-19).
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Figure 6 cont. E,F. mCD4-EnvCT and WT Env have differing diffusion
modalities in both the 12LE and 12LE/34VI mutant MA lattices, shown by SMSS
and Dapp in scatter-histograms. Red dashed line indicates SMSS > 0.17, Brownian
motion cutoff. Black dashed line indicates the mean Dapp for WT Env/MA
diffusion. All error represents SD.
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Monomeric EnvCT competes with native Env trimers for virion
incorporation
Our results demonstrate that mCD4-EnvCT phenocopies the dependence
on the MA-12L residue for trapping and retention when compared to native
Env trimers. We next sought to determine if the regions of the MA lattice that
interact with the Env-CT are identical or overlapping between monomeric
Env-CT and native Env trimers. We designed a competition assay to
determine if monomeric Env-CT can saturate the MA lattice-interacting
regions and inhibit native Env trimer incorporation. Co-expression of mCD4
chimeras and WT Env would likely give rise to binding and clustering during
biosynthesis, as the CD4 ectodomain interacts with Env for mediating HIV-1
entry (Willey et al., 1992; Lama et al., 1999; Ross et al., 1999). To ameliorate
this issue, we designed a synthetic Env-CT chimera, consisting of a HA
epitope-HaloTag ectodomain linked to the transmembrane domain of lowdensity lipoprotein receptor (LDL) (Kenworthy et al., 2004; Pralle et al., 2000).
The C-terminus of this synthetic type-I integral membrane receptor was then
fused to either the Env-CT (possessing the 712YA mutation) or a ΔCT
truncation mutant, creating HA-Halo-gt-EnvCT and -∆CT, respectively
(Appendix Figure 9). We then produced particles by co-transfecting the
synthetic HaloTag constructs with NL4-3 pol(-) Env-712YA in a range of molar
ratios (0:1.375 mol/mol, respectively). VLPs incorporated both WT Env and
Env-CT chimeras. Importantly, increasing concentrations of monomeric HAHalo-gt-EnvCT restricted incorporation of WT Env trimers in a dose57

dependent manner (IC50=0.3 molHA-Halo-gt-EnvCT/molNL4-3,WT-Env) (Figures 7A, 7B,
7E, and 7G). We determined that this result was dependent upon the Env-CT
as the tailless HA-Halo-gt-ΔCT failed to inhibit trimeric Env-712YA
incorporation (Figures 7C, 7E, and 7G). Consistent with the observation that
the monomeric Env-CT is incapable of enriching in MA-12LE/34VI particles,
no inhibition of native Env incorporation was observed in this mutant
background (Figures 7D, 7E, and 7G); this result suggests that Env-CT
overexpression does not perturb upstream Env biosynthesis and trafficking.
We also sought to test whether the NL4-3 Env-CT chimera could inhibit native
Env incorporation of a transmitted founder virus from another clade. To test
this, we put an HIV-1 Clade C transmitted/founder (T/F) clone, ZM247fv1,
against our monomer in the assay. We observed that HA-Halo-gt-EnvCT
exhibits inhibition of ZM247fv1 Env incorporation similar to NL4-3 Env
(Figures 7F and 7G). We have observed a failure of monomeric Env-CT to
inhibit incorporation of YFP-MLV-Env in the NL4-3 lattice—consistent with the
pseudotyping capabilities of MLV-Env (Appendix Figure 10). Finally, we show
show that HA-Halo-gt-EnvCT can itself be saturated on released particles
(Appendix Figure 11), similar to previous observations with native HIV-1 Env
overexpression (Qi et al., 2013). Together, these results support a model in
which a single Env-CT is sufficient for occupation of the same incorporation
sites of Env trimers in the WT MA lattice and suggest that the nature of
interaction between these species may be relegated to a few secondary or
tertiary contact points that are highly conserved across clades.
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Figure 7 Monomeric EnvCT competes with native Env trimers for virion
incorporation. A. Representative western blots of VLPs and cell lysates for
competitive inhibition experiments using Env 712YA with increasing plasmid
concentrations of monomeric HA-Halo-gt-EnvCT(712YA). B. A dose-response
curve was estimated using a sigmoidal fit (IC50 = 0.3 molgt/molNL4-3; mean square
error = 1.2×10-3).
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Figure 7 cont. C. Western blots demonstrating that HA-Halo-gt-∆CT does not
compete with Env 712YA with increasing plasmid ratios (0, 0.625, and 1.375 molgt/molNL4-3). D. Western blots showing monomeric HA-Halo-gt-EnvCT cannot
inhibit WT Env incorporation in the 12LE/34VI mutant MA lattice. For all western
blots, gp41 (Env 712YA) and HA-Halo-gt-EnvCT were detected with anti-EnvCT
(Chessie8) mAb, Gag was detected with anti-p24 (183-H12-5C) mAb, and the
HA epitope with anti-HA (H17-L2) mAb. E. Double exponential loss curve of the
competitive inhibition of 712YA Env with half-maximal inhibition occurring at
0.6±0.1 gp41/Pr55 (vertical dashed line represents half-maximum of inhibition;
root mean square error of fit = 0.04).
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Figure 7 cont. G. Comparisons of the mean gp41/Pr55 ratio between all assays
performed at 0.625 molgt/molNL4-3 plasmid ratios (MA-WT/Env-712A versus MAWT/gt-∆CT: P=0.02; MA-WT/Env-712YA versus MA-12LE-34VI/gt-EnvCT:
P=0.04; MA-WT/gt-∆CT versus MA-12LE-34VI/gt-EnvCT P=0.15, MA-WT/Env721YA versus ZM247Fv1/gt-EnvCT: P=0.69). Error bars represent SD.
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Discussion
Herein, we suggest that the fundamental structure mediating Env –
Gag coalescence is likely simpler than a complex quaternary surface and
likely comprises a secondary or tertiary conformation of a single Env-CT. A
major hurdle for studying the Env-CT and Gag MA retention mechanism is
decoupling the influence of the trimer structure of gp41 from CT specific
function. By producing a chimeric Env-CT monomer, we have been able to
show biochemically that a single Env-CT is sufficient for virus particle
incorporation. We demonstrate that incorporation of this mCD4-EnvCT
monomer is CT dependent in A2.01 t-cells, however we sought to understand
whether these monomers could be retained similarly to WT Env trimers .
Previously we have demonstrated that measuring diffusional confinement of
the Env-CT at sites of Gag lattice assembly can discern passive incorporation
and pseudotyping from bona-fide Env-CT retention in the viral lattice (Buttler
et al., 2018; Groves et al., 2020; Pezeshkian et al., 2019). We speculated that
it would be possible for a single Env-CT to have some preference for
assembly sites in the absence of a quaternary baseplate tail structure, but still
be able to diffuse through the lattice without strong retention. Using our
single-particle tracking methodology, we were able to show that a monomeric
Env-CT is sufficient for diffusional confinement at HIV-1 assembly sites with a
similar strength of retention to that of WT Env trimers. We find that these
radically different structures share nearly identical traits for incorporation and
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retention—suggesting that trimeric Env may only rely on one of its three tails
to be retained in the viral bud.
Furthermore, we evaluated whether perturbations to the Gag-MA layer
would abrogate monomeric Env-CT incorporation in a similar way to Env
trimers. We found that the monomer is readily incorporated into released
particles in a MA-dependent manner and recapitulates the trimer diffusivity in
the defective MA-12LE budding Gag lattice. We speculate that the 12LE
mutation may permeablize the MA layer, allowing for Env to pass through the
lattice with lower probability of retention through steric coralling. It is also
possible that 12LE-MA introduces conformational changes in the lattice that
may hide motifs that potentiate an Env-Gag interaction. Surprisingly,
introduction of the 34VI mutation into the MA-12LE lattice can rescue Env
trimer, but not monomer, incorporation and retention. Following our
reasoning, if 12LE loosens the lattice or hides Env-CT interacting regions,
then 34VI must either partially stabilize the lattice enough for only trimers to
become corralled or create a new, orthogonal interface specifically for Env
trimer retention.
We have additionally shown that a monomeric Env-CT is saturable for
particle incorporation and this monomer can dose-dependently outcompete
Env trimer incorporation. These results suggest that a single tail provides
either the necessary size and/or binding conformer requirements and these
interaction regions are limited at each virus assembly site. Consistent with
this hypothesis, HIV-1 particles are decorated with only 7-14 Env trimers (Zhu
63

et al., 2006, 2003). The primary reason for this is thought to be for immune
evasion, however it is unclear how this occurs, as there are roughly a
thousand predicted Gag MA trimers in the immature lattice that could
potentiate Env incorporation, and we have observed an excess of Env trimers
that laterally diffuse along the host cell plasma membrane (West et al., 2002;
Ganser-Pornillos et al., 2012; Pezeshkian et al., 2019; Groves et al., 2020). If
every MA trimer were able to interact with an Env-CT, there should be 100fold more Env trimers per particle than is observed. Collectively, this suggests
that heterogeneous MA lattice regions exist that accommodate a minimal
Env-CT tail structure, potentially within defects that evolve in the MA lattice
structure (Fuller et al., 1997; Tan et al., 2021). This hypothesis is supported
by a recent cryo-EM structure demonstrating that the immature MA lattice of
HIV-1 particles is heterogeneous (Qu et al., 2021). It is also possible that the
incorporation mechanism relies heavily on building a strong diffusion barrier,
largely inhibiting entry of Env into the MA lattice. Consistent with this
hypothesis, we have observed clustering of Env trimers at the neck of
budding viruses, suggesting that Env trimers associate more frequently with
the edges of the Gag lattice (Buttler et al., 2018). It is intriguing to speculate
that native Env trimers can undergo conformational changes between a
folded quaternary baseplate structure and a more linear structure, reconciling
the disparate in vitro structures of the Env-CT (Murphy et al., 2017; Piai et al.,
2021), with the linear structure conformation mediating MA lattice entry. Our
work showing that a clade B monomeric Env-CT can inhibit incorporation of a
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clade C T/F virus Env into it’s matching Gag lattice implies that these
mechanisms may be highly conserved amongst the diverse sea of HIV
strains. This is critically important to the development of future incorporation
antagonists, as they may prove to be pan-HIV neutralizing if they target the
specific Env-Gag interface observed in our findings. Overall, this work
suggests that a unique single Env-CT accommodation region exists in the MA
layer and that understanding this interface will be key for developing novel
HIV-1 assembly antagonists.
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Chapter Four: Concluding remarks and future directions
Introduction
In the previous chapters I have demonstrated a live-cell superresolution
assay for evaluating the strength of retention of single-molecules in the HIV-1
Gag lattice as well as shown that a monomeric Env-CT is sufficient for
incorporation and retention in HIV-1 assembling virions. While this demonstrates
a significant advancement in our ability to understand the biophysical
mechanisms of viral spike retention, the bodies of work presented aresteppingstones for future developments.
The viral spike Env must be incorporated into virus particles for HIV-1 to be
infectious. Importantly, our work shows that a synthetic monomeric cytoplasmic
tail can disrupt this. Naturally, this finding evokes prospects of future drug
therapeutics that may rely on similar synthetic restriction factors. While there are
many anti-retrovirals (ARTs) for HIV available, there is still an emergent need for
more until a cure is discovered. HIV is highly mutagenic and frequently evades
ART-. These ART resistant variants continue to pose a threat to the individuals
and public health infrastructure. It is through further understanding of the EnvGag interface that the first therapeutic to target virus assembly may be birthed.

66

While the entire Env-CT acts as a restriction factor for native Env
incorporation, it would be challenging to develop a peptide mimetic for the
approximately 144 amino acid structure. The structure of the Env-CT is
comprised of three domains and four putative amphipathic alpha-helices (Murphy
et al., 2017). These domains are called lentivirus lytic peptides (LLP) 1, 2, and 3.
These domains are membrane proximal and are ordered from the
transmembrane to C-terminus as LLP2, LLP3, LLP1, respectively (Figure 8). The
first domain, LLP2, is thought to contain endocytic and trafficking motifs
necessary for Env biogenesis and recycling, while the LLP3 and LLP1 domains
have been previously shown to interact with the Gag-MA layer in vitro (Alfadhli et
al., 2009b). Herein I present some preliminary data showing the retention
strength, incorporation, and competitive nature of these domains, while
demonstrating the utility of quantifying retention and bulk incorporation.
Quantifying retention of individual Env-CT domains in the HIV-1 Gag lattice
To understand the retention of individual domains, I used the singleparticle tracking assay previously described to track chimeric truncation mutants
of the Env-CT (Groves et al., 2020) (Figure VIII). Using the same synthetic mCD4
construct, I fused truncated products of the Env-CT to the transmembrane
domain using a glycine-serine repeat spacer to allow for conformational flexibility.
In the viral lattice, LLP3 and LLP3-1 Env-CT truncation mutants exhibit similar
retention as measured by SMSS and Dapp, however diffuse more freely than the
full-length Env-CT monomer. The LLP3 and LLP3-1 molecules diffuse with a
more confined nature than the CT deleted monomer when proximal to the Gag
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lattice, and exhibit some weak retention (Figure 8). This suggests that the LLP3
and LLP1 domains may have a partial role in Env incorporation. It is possible that
the structure of these domains may not be similar to the full-length CT, or that
steric corralling or lipid microdomains may contribute stronger retention of full
length Env-CT monomers.
I also chose to also examine the retention of a full-length mutant Env-CT
to see if changing the structural characteristics of LLP3 would inhibit retention in
the Gag lattice. Previously, the mutant d6 Env-CT was shown to have an
incorporation and infectivity defect when introduced in native Env trimers
(Murakami and Freed, 2000). The d6 mutation is a deletion of the Y801/W802
residues in LLP3. This mutant is created as a deletion rather than a mutation due
to the nature of the env and rev reading frame overlap in the HIV-1 genome
(Ganser-Pornillos et al., 2012). The synthetic mCD4-EnvCT monomer construct
is not constrained by these reading frame overlaps. Rather than deleting this
region, I chose to mutate the residues to alanine, creating Y801A/W802A
(YWAA). Surprisingly, this mutant showed similar strength of retention to that of
the WT Env-CT monomer, indicating that the d6/YW motif is unnecessary for Env
incorporation (Figure 8). This contradicts previous results demonstrating a role
for this YW motif in virus infectivity(Murakami and Freed, 2000). However, we
now appreciate that the Env trimer constitutes a quaternary baseplate structure
that may be functionally disrupted by a mid-alpha helix deletion such as d6, as
these YW motifs seem to make inter-LLP contacts in the quaternary structure
(Piai et al., 2021).
68

To further demonstrate the importance of a single-molecule assay of this
nature, I have performed a biochemical Env incorporation assay using the
monomeric LLP3 chimera in the WT, 12LE-MA, and 12LE/34VI-MA lattices
(Figure 9). The bulk biochemical incorporation of the LLP3 monomer is measured
through virus isolation using ultracentrifugation as described in the methods
above. The western blot of LLP3 monomer incorporation suggests that it is
incorporated into virus-like particles in an MA-dependent manner. The 12LE
mutant Gag lattice disrupts WT Env trimer incorporation and here I show that
12LE causes a significant reduction in LLP3 incorporation, while 34VI may this
partially rescue defect. Using only this biochemical data, it could be concluded
that LLP3 is sufficient for Env incorporation into the lattice, however, singleparticle tracking has demonstrated a partial defect for retention. These results
together suggest that the LLP3 helix may be critical for initial binding to the MA
lattice, yet is not sufficient to lock the Env-CT into the lattice as observed for WT
Env (Pezeshkian et al. 2019). While LLP3 is only partially retained compared to
the full-length Env-CT monomer, it is MA dependent—indicating a preference for
the WT MA lattice. This corroborates my hypothesis, that LLP3 may partially
contribute to Env incorporation but is not completely sufficient for incorporation.
In this respect, it may be the bulkiness of the full-length Env-CT that further helps
retain a weak directly-interacting interface between MA and LLP3.
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Figure 8. Diffusion characteristics of Env-CT mutants at virus assembly sites.
The monomeric cytoplasmic tail of Env (Gray structure, PDB: 5VWL), was
truncated and mutated for creation of a mCD4 chimeric monomer. Truncated
Env-CT chimeras were tracked to measure Dapp and SMSS. Truncation mutants,
LLP3 and LLP3-1, exhibit partially defective retention in the lattice when
compared to WT Env and full-length Env-CT monomers.
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Figure 9. The truncated LLP3 chimera (LLP-3 highlighted in Red) exhibits GagMA dependence. MA-12LE abrogates LLP3 chimera incorporation while
introduction of 34VI may partially rescue this defect.
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Examining individual Env-CT domains as viral restriction factors
While I have identified LLP3 as a potential weak interacting partner for
Gag-MA, previous work suggests that LLP1 may have a role in Env incorporation
(Alfadhli et al., 2009b). To further investigate this, I performed a sequence
alignment of the Env-CT. The alignment predicts a conserved region at the end
of LLP1 in the putative helix-2 (LLP1-h2) (Figure 10). This 15 amino acid long
peptide contains a proline kink region that divides the LLP1 domain, and contains
a di-leucine motif at the C-terminus. I hypothesized that this amphipathic peptide
could potentially be expressed in high abundance with a soluble tag, or attached
to a PM targeting peptide to inhibit native Env incorporation. Herein, I
demonstrate the utility of the competitive inhibition assay for screening potential
peptide mimetics of the monomeric Env-CT.
To see whether this small and conserved region in LLP1 could abrogate
native Env incorporation, I created eGFP-LLP1-h2 (soluble peptide) and S15LLP1-h2 (membrane targeting peptide) constructs in the pLJM1 backbone as
previously described (see Materials and Methods Chapter 3). The constructs
were designed so that the hydrophobic helix would either be solubilized by eGFP
in the cytoplasm, or targeted to the PM by S15—the fifteen amino acid
myristoylation signal from v-SRC. These constructs were co-transfected at 0.5
mol per 1 mol HIV-1 NL4-3 plasmid into HEK 293T cells as previously described.
The subsequent virus-like particles produced were harvested by
ultracentrifugation and analyzed by western blot for native Env incorporation.
Both S15-LLP1-h2 and eGFP-LLP1-h2 were able to reduce WT Env
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incorporation, although eGFP-LLP1-h2 did to a lesser extent (Figure 11). The
S15-LLP1-h2 peptide inhibited approximately 20% of total Env incorporation,
while full-length Env-CT was able to cause a 50% reduction (Results Chapter 3).
It is possible that LLP1-h2 has partial contribution to full-length Env-CT
incorporation, similar to LLP3, which may explain the ability of LLP1-h2 to
partially inhibit WT Env incorporation. Further examination of LLP1-h2 retention
is therefore required.
Concluding remarks
Herein, I have provided a framework for the characterization of singlemolecule retention at sites of HIV-1 virus assembly using live-cell single-particle
tracking with simultaneous superresolution reconstruction. Utilizing this
methodology in tandem with bulk biochemical analysis, I have shown that that a
single Env-CT is sufficient for incorporation and retention in the viral lattice, and
that the quaternary baseplate has no function in the HIV-1 assembly process.
Through examining a handful of these Env-CT regions, I have observed that
both LLP3 and LLP1 contribute to partial retention in the Gag lattice. Although
further work is necessary to validate these observations, I hypothesize that these
domains may act synergistically and cooperatively to retain Env through a direct
interaction with PM proximal Gag-MA. The MA lattice has defects visible at the
molecular level which may accommodate a conformer of the LLP3 and LLP1
domains (Figure 12A and B) (Tan et al., 2021). It’s possible that these domains
could bend at the unstructured hinge and rest in an MA defect pocket. It is also
plausible that there is some conformer of the Env-CT that can lay across an
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intact MA trimer interface—stabilized by the LLP3 and LLP1 interactions with MA
(Figure 12C). Such claims may be supported by showing inhibition of WT Env
incorporation by co-expressing the individual LLP3 and LLP1-h2 chimeric
proteins in tandem, or through visualization of the ultra-structure of Env-CT and
Gag-MA in virions. Results from experiments such as this will continue to push
forward the boundary of knowledge surrounding the assembly of infectious HIV,
and may contribute to the formation of future antiretrovirals.

74

Figure 10. Alignments of the C-terminal region of the Env-CT elucidates
conserved residues near the LLP1 domain.
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Figure 11. The highly conserved LLP1-h2 domain (Red) was fused to the Cterminus of S15 or eGFP and co-transfected with NL4-3 to determine the
strength of competitive inhibition. LLP1-h2 chimeras exhibit minimal competitive
inhibition of WT Env incorporation compared to full-length HA-Halo-gt-EnvCT
chimeras.
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Figure 12.
Potential structural changes in the Env-CT to fill MA lattice accommodation
regions. A. Env-CT distal to the lattice sits in the membrane. B. The Env-CT
LLP3 and LLP1 regions fit as a hinge in lattice defect pockets (Red asterisk).
This hinge may bind through reducing any energy penalty created by the
defective trimer. C. The LLP3 and LLP1 region of the Env-CT may undergo a
mild conformational change to reach multiple Gag binding partners. The Env-CT
may rely on the combined affinity of LLP3 and LLP1 to stay associated with the
Gag lattice.
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Appendix Figure 1. Simulations of localizations and reappearances required for
reconstruction and centroid finding of assembly sites. (A) Using a sphere
constrained by the discontinuous polar angle ranges ( 5π/3 , π/3 ) and ( 2π/3 ,
4π/3 ), we simulated arrangements of pseudo-random molecules labeling a Gag
shell. These constraints were selected because the CA-Skylan-S probe is unable
to label a budding lattice at the bottom most region of the assembly site since the
neck is open.Further, it is likely that the CA-Skylan-S probe labels the crown of
the lattice with low frequency, since there are proximal Gag molecules near the
cytosolic entrance at the neck and equator of the assembly site. (B) Localizations
are then pseudo-randomly displaced to mimic localization uncertainty measured
in this study. (C) Reconstructions of X- and Y-FWHM approach the
experimentally determined mean FWHM of ≈138 nm for all degrees of molecular
reappearances (α). (D) The X and Y centroids describe the lateral origins of the
Gag sphere with accuracy at or below the localization uncertainty. Gray regions
indicate the localization cutoff used in this study (5 localizations) for
reconstructing bona-fide assembly sites with the CA-Skylan-S probe. Error bars
represent standard deviation. These simulations suggest that our experimental
system estimates the size and centroid of virus assembly sites through
localization of more than one CA-Skylan-S molecule labeling the Gag lattice, with
these probes likely exhibiting more than one molecular reappearance
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Appendix Figure 2
Distribution of Skylan-S localizations at single virus assembly sites. A. The mean
number of localizations for the ensemble of assembly sites measured was
determined by fitting to a lognormal distribution. On average, 23 localizations
were found at assembly sites after filtering out localizations with uncertainties
below 40 nm and eliminating assembly sites with less than 5 localizations.
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Appendix Figure 3
Full-width at half-maximum (FWHM) anisotropy in X- and Y-dimensions. (A)
Pairwise FWHM anisotropy was calculated for all independent assembly sites by
the equation X-FWHM / Y-FWHM . This fractional FWHM was fit to a lognormal
distribution, with mean µ = 1.09 and standard deviation equal to ≈ 4% of X- and
Y-FWHM measurements. This slight anisotropy results in approximately 5.7 nm
of uncertainty in the centroid position, only 17% of our mean localization
precision.
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Appendix Figure 4
BG18-QD625 design and production. (A) Recombinant bacterial expression
system for production of BG18 containing an unnatural amino acid (UAA). E. Coli
strains selected for both pCOMB3H-BG18-Amber fab and H-4-azidophenylalanine(pAzF) tRNA/ tRNA-synthetase expression plasmids produce UAAincorporated light chain BG18 upon pAzF-charged tRNA anticodon (AC)
recognition of the Amber stop codon. (B) The incorporation of the UAA allows for
noncanonical expression of p-azido-L-phenylalanine thereby, providing a site for
a quantum dot click reaction as well as a His-(×6) tag for purification of UAAincorporated fab (R = BG18 fab). (C) Cartoon protocol for the purification of
BG18-QD625: (1) Metal-ion affinity chromatography of Amber-suppressed BG18
fab possessing a hexahistidine repeat after the pAzF UAA, (2) purified BG18pAzF fab is then conjugated to DIBO-QD625 using copper-free click chemistry,
(3) unreacted DIBO-QD625 is subsequently removed from BG18 fab by affinity
chromatography using anti-human IgG CH1-domain resin, (4) unlabelled BG18pAzF fab is then removed from the BG18-QD625 conjugates using a 100 kDa
molecular-weight cutoff filter. (D) Molecular cartoon of the BG18-QD625
conjugation strategy using the copper-free click chemistry reaction. The covalent
coupling reaction occurs between the strained alkyne group and the azide
moiety. (E) SDS-PAGE of flowthrough, wash, and elution fractions after BG18
purification from both metal-ion and CH1XL affinity chromatography. Heavy and
light chains of fab complexes are purified to near homogeneity in stoichiometric
abundance as assessed by Coomassie R-250 staining.

101

Appendix Figure 5
Fluorescence crosstalk of Skylan-S is insignificant and does not lead to
localization artifacts in the QD625 channel. (A) Single images for CA-Skylan-S
labelling of the Gag lattice (Gag, 50 ms integration) and BG18-QD625 (Env, 10
ms integration). White box highlights a region of high signal intensity for the CASkylan-S channel (scale bars = 5 µm). (B) The fluorescence density of the white
bounded region of interest in A. No appreciable signal is observed in the BG18QD625 channel compared to the CA-Skylan-S channel in this region of interest.
(C) Point localization reconstructions of the field of view in A. Insets highlight the
peak signal intensity in B. In this region void of true BG18-QD625 signal, no point
localizations are detected by the peak finding algorithm (scale bar = 5 µm, inset
scale bar = 500 nm.)
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Appendix Figure 6
Fluorescence intensity of Immobilized QD625 remains relatively constant over
relevant acquisition times and excitation intensities. (A) Montage of QD625
evenly sampled over the acquisition period graphed in B (10 ms integration). (B)
Fluorescence density from the 9 × 9 pixel area defining static QD625 in A (n =
1753 image frames, Black: Fluorescence Density (a.u.) of individual frames, Red:
100 frame window moving average). Fluorescence fluctuations are present,
however no appreciable photobleaching or dimming is detected (5 percent
decrease in fluorescence density over 17.53 seconds). Fluctuations in intensity
are likely due to stochastic fluctuations in excitation intensity, fluorescence
transitions, and camera noise.
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Appendix Figure 7
CD4(318KE)-EnvCT chimeras form stable monomers on expressing cells.
Bissulfosuccinimidyl suberate (BS3) crosslinking of A2.01 (CD4-null) cells
expressing mCD4-EnvCT (left lane) or mCD4-Env∆CT (middle lane) does not
result in the accumulation of higher-order oligomers, suggesting that both CD4318KE and the Env-CT are incapable of driving multimerization of the chimeric
constructs. The parental A3.01 cell line endogenously expresses CD4. BS3
crosslinking of endogenous CD4 demonstrates that CD4 exits in oligomeric forms
(right lane; CD4 multimer), demonstrating that the 318KE mutation and removal
of the CD4-CT relegates Env-CT chimeras to a monomeric form. Native CD4 and
mCD4 chimeras were detected by western blotting with anti-CD4 antibody
(ab133616).
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Appendix Figure 8
Cumulative displacements of single molecule trajectories in proximity to
HIV-1 assembly sites. A. X- and Y- full-width at half-maximum (FWHM)
estimates of individual single molecule trajectory positions at single virus
assembly sites. Distributions of the FWHM were fit to a lognormal distribution for
both WT Env (left column) and chimeras (right column) proximal to WT (top row),
12LE (middle row) and 12LE/34VI (bottom row) MA lattices. B. Non-parametric ttests were performed across all FWHM distributions. No statistical significance
was observed for the displacement of single molecule trajectories for either
trimers or chimeric monomers proximal to WT MA, and trimers proximal to
12LE/34VI MA, suggesting that those single molecules trapped at virus assembly
sites all exhibit similar confinement (sub-40 nm FWHM distribution). An arbitrary
reference of 40 nm FWHM is indicated using a red vertical dash line to highlight
distribution shifts for the genotypes listed. C. Aggregate single molecule
localization precision (σ) for entire study. Top panel is the uncertainties for the
QD-625 probe (mean σ=11±4 nm, n=95599) and bottom panel for the CASkylanS probe (mean σ=30±7 nm, n=580452) after filtering all localizations with
uncertainties above 40 nm.
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Appendix Figure 9
Design for HA-Halo-gt-EnvCT monomeric chimeras. To remove influence
between the interaction with native Env trimers and the ectodomain of CD4, we
designed an orthogonal Env-CT chimera. This alternative chimera utilizes a
soluble HA-Halo tag ectodomain (gray, PDBID: 5Y2Y) with an N-terminal fusion
to the CD4 secretory signal peptide (not depicted). This ectodomain was then
fused to an N-linked glycosylation signal sequence and the transmembrane
domain of the low-density lipoprotein receptor (LDLR-TMD). This was finally
fused to either the full-length HIV-1 Env-CT (magenta; PDBID: 5VWL) or to the
short Chessie 8 peptide recognition region of Env-CT (green; ∆CT).
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Appendix Figure 10. Competitive inhibition of MLV-Env. YFP-MLV-Env was
co-transfected with Env deleted NL4-3 and HA-Halo-gt-EnvCT to examine
strength of competitive inhibition. MLV Env incorporation was enhanced by
expression of the HA-Halo-gt-EnvCT chimera, rather than being inhibited like
NL4-3 and Clade C Env (P=0.019).
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Appendix Figure 11. HA-Halo-gt-EnvCT incorporation is saturable in
HEK293T-derived pseudovirus. Increasing amounts of HA-Halo-gt-EnvCT (gt)
plasmid were co-transfected into HEK293T cells with pSVNL4-3-pol(-)-Env712YA (NL4-3; Pr55 = Gag). The data points at increasing concentrations were
fit to a double exponential recovery curve (HA-Halo-gt-EnvCT curve evaluated at
infinity: YInfinity = 1.24 molgt/molNL4-3, root mean square error = 0.11). The
saturation curve of HA-Halo-gt-EnvCt evaluated at the IC50 of WT Env (0.6 molgt/molNL4-3) is approximately 0.5 molgt/molNL4-3. The near intersection of these
curves at the 712YA Env IC50 indicates a similar MA lattice preference for trimers
and monomers. The incomplete loss of WT Env during competition may be
attributed to shed micro-vesicle contamination or another, trimer specific,
incorporation mechanism that cannot be accessed or accommodated by a
monomeric Env-CT. Error bars represent SD.
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